The first Summit Therapeutics trade was made in Q3 2020.
Since then Jim Simons bought shares three more times and sold shares on five occasions. The investor sold all their shares in Q1 2023 and doesn't own any shares in Summit Therapeutics anymore.
Avg closing price
Price range
Sold -23.3 Thousand shares
Q1 2023
Avg closing price
$2.73
Price range
$1.38
-
$5.41
New holding (+23.3 Thousand shares)
Q4 2022
Avg closing price
$1.82
Price range
$0.68
-
$5.31
Sold -49.1 Thousand shares
Q3 2022
Avg closing price
$1.13
Price range
$0.89
-
$1.63
New holding (+49.1 Thousand shares)
Q2 2022
Avg closing price
$1.40
Price range
$0.92
-
$2.38
Sold -125 Thousand shares
Q3 2021
Avg closing price
$7.18
Price range
$4.83
-
$8.27
Increased shares by 82.8% (+56.8 Thousand shares)
Q2 2021